CMS
67
2
ABBV
57
6
KR
52
3
MA
64
4
RL
73
-3
KO
50
4
FTI
76
5
PRGO
39
2
LEN
59
4
PCG
83
3
APH
55
-4
WDC
59
-2
CCL
68
4
HCA
70
-3
DVN
25
4
BMY
63
3
DVA
75
2
ISRG
66
-2
VRSN
60
3
FFIV
67
-3
CMS
67
2
ABBV
57
6
KR
52
3
MA
64
4
RL
73
-3
KO
50
4
FTI
76
5
PRGO
39
2
LEN
59
4
PCG
83
3
APH
55
-4
WDC
59
-2
CCL
68
4
HCA
70
-3
DVN
25
4
BMY
63
3
DVA
75
2
ISRG
66
-2
VRSN
60
3
FFIV
67
-3
Financhill
Back

Smith Douglas Homes Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
45

SDHC
Smith Douglas Homes

Last Price:
36.90
Seasonality Move:
--
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Sell
45
Smith Douglas Homes (SDHC) is a Sell

Is Smith Douglas Homes a Buy, Sell or Hold?

  • The current Smith Douglas Homes [SDHC] share price is $36.90. The Score for SDHC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • SDHC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SDHC Stock Price Chart

What is Smith Douglas Homes's stock price today?

  • The Smith Douglas Homes share price today is $36.90
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SDHC is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

SDHC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.64 Buy
Relative Strength Index (14 RSI): 56.06 Buy
Chaikin Money Flow: 63209 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.73 - 37.35) Buy
Bollinger Bands (100): (24.61 - 34.91) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

SDHC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.58 Buy
20-day SMA: 35.87 Buy
50-day SMA: 34.21 Buy
200-day SMA: 0 Buy
8-day EMA: 36.22 Buy
20-day EMA: 35.9 Buy
50-day EMA: 33.84 Buy
200-day EMA: 0.37 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Smith Douglas Homes Earnings Growth & SDHC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.11 per share, and an increase next year of $0.45 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Smith Douglas Homes Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):